Krista Fager
- Hematology top 5%
- Oncology
- Genetics top 10%
- Molecular Biology
- Rheumatology top 10%
- Co-authors
- Amy CamusoKelly McGlincheyChristine FleflehIvan InigoDavid KanStephen CastanedaZheng YangRobert A. Kramer
- Topics
- Chronic Lymphocytic Leukemia Research (6 papers)Chronic Myeloid Leukemia Treatments (6 papers)HER2/EGFR in Cancer Research (4 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- United StatesGermany
In The Last Decade
Krista Fager
11 papers receiving 366 citations
Peers
Comparison fields: 5 of 51
- Hematology 161
- Oncology 135
- Genetics 114
- Molecular Biology 113
- Rheumatology 84
Countries citing papers authored by Krista Fager
This map shows the geographic impact of Krista Fager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krista Fager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krista Fager more than expected).
Fields of papers citing papers by Krista Fager
This network shows the impact of papers produced by Krista Fager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krista Fager. The network helps show where Krista Fager may publish in the future.
Co-authorship network of co-authors of Krista Fager
This figure shows the co-authorship network connecting the top 25 collaborators of Krista Fager. A scholar is included among the top collaborators of Krista Fager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krista Fager. Krista Fager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 113 | |
| 3 | 60 | |
| 4 | BMS-354825 potently inhibits multiple selected oncogenic tyrosine kinases and possesses broad-spectrum antitumor activities in vitro and in vivo | 38 |
| 5 | 66 | |
| 6 | 22 | |
| 7 | 14 | |
| 8 | 5 | |
| 9 | Pharmacodynamic analysis of target inhibition and tumor endothelial cell death in biopsies obtained from patients treated with the VEGF receptor antagonists SU5416 or SU6668 | 3 |
| 10 | 1 | |
| 11 | 9 |
About Krista Fager
Krista Fager is a scholar working on Genetics, Hematology and Oncology, having authored 11 papers that have together received 374 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Hematology (161 citations), Genetics (114 citations) and Rheumatology (84 citations). Krista Fager has collaborated with scholars based in United States and Germany. Frequent co-authors include Amy Camuso, Kelly McGlinchey, Christine Flefleh, Ivan Inigo, David Kan, Stephen Castaneda, Zheng Yang, Robert A. Kramer, Feng Luo and Francis Y. Lee. Their work appears in journals such as Blood, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.